Previously Known As : Sbi Pharma Fund
Sbi Healthcare Opportunities Fund Datagrid
Category Pharma Fund
BMSMONEY Rank -
Rating
Growth Option 12-06-2026
NAV ₹472.17(R) +0.51% ₹545.63(D) +0.51%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 10.66% 25.21% 15.51% 23.12% 13.36%
Direct 11.79% 26.52% 16.74% 24.44% 14.61%
Nifty Pharma TRI 11.55% 24.71% 11.87% 17.8% 9.34%
SIP (XIRR) Regular 18.54% 17.17% 19.63% 20.95% 18.16%
Direct 19.71% 18.4% 20.89% 22.26% 19.38%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
1.2 0.63 1.09 4.2% -0.46
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
14.75% -15.67% -12.33% 0.81 10.7%
Fund AUM As on: 30/12/2025 4058 Cr

NAV Date: 12-06-2026

Scheme Name NAV Rupee Change Percent Change
SBI Healthcare Opportunities Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW) 297.44
1.5200
0.5100%
SBI Healthcare Opportunities Fund - Direct Plan - Income Distribution cum Capital Withdrawal Option (IDCW) 379.08
1.9400
0.5100%
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 472.17
2.4100
0.5100%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 545.63
2.7900
0.5100%

Review Date: 12-06-2026

Beginning of Analysis

The Sbi Healthcare Opportunities Fund has shown an excellent past performence in Pharma Fund. The Sbi Healthcare Opportunities Fund has a Jensen Alpha of 4.2% which is higher than the category average of 0.91%. Here the Sbi Healthcare Opportunities Fund has shown very good performance in terms of risk adjusted returns. The Sbi Healthcare Opportunities Fund has a Sharpe Ratio of 1.2 which is higher than the category average of 1.01. Here the Sbi Healthcare Opportunities Fund has shown very good performance in terms of risk adjusted returns.
The past performance of the {fund_name_eng} may or may not be sustained in the future. The review is not investment advice nor is it a recommendation to buy or sell funds.
Pharma Mutual Funds

Sbi Healthcare Opportunities Fund Return Analysis

The Sbi Healthcare Opportunities Fund has delivered a mixed performance across various time horizons, showcasing both strengths and challenges when compared to its Pharma Fund peers and the Nifty Pharma TRI benchmark. This analysis examines the fund’s returns over periods ranging from one month to ten years, alongside its Systematic Investment Plan (SIP) performance, highlighting its rankings within the Pharma Fund category and its ability to outperform or underperform the benchmark and category averages.

  • The fund has given a return of 3.74%, 10.98 and 11.64 in last one, three and six months respectively. In the same period the category average return was 3.16%, 9.88% and 9.06% respectively.
  • Sbi Healthcare Opportunities Fund has given a return of 11.79% in last one year. In the same period the Nifty Pharma TRI return was 11.55%. The fund has given 0.24% more return than the benchmark return.
  • The fund has given a return of 26.52% in last three years and rank 4th out of eight funds in the category. In the same period the Nifty Pharma TRI return was 24.71%. The fund has given 1.81% more return than the benchmark return.
  • Sbi Healthcare Opportunities Fund has given a return of 16.74% in last five years and category average returns is 15.12% in same period. The fund ranked 1.0st out of eight funds in the category. In the same period the Nifty Pharma TRI return was 11.87%. The fund has given 4.87% more return than the benchmark return.
  • The fund has given a return of 14.61% in last ten years and ranked 4.0th out of four funds in the category. In the same period the Nifty Pharma TRI return was 9.34%. The fund has given 5.27% more return than the benchmark return.
  • The fund has given a SIP return of 19.71% in last one year whereas category average SIP return is 17.26%. The fund one year return rank in the category is 5th in 15 funds
  • The fund has SIP return of 18.4% in last three years and ranks 2nd in 8 funds. Uti Healthcare Fund has given the highest SIP return (18.47%) in the category in last three years.
  • The fund has SIP return of 20.89% in last five years whereas category average SIP return is 18.62%.

Sbi Healthcare Opportunities Fund Risk Analysis

  • The fund has a standard deviation of 14.75 and semi deviation of 10.7. The category average standard deviation is 15.97 and semi deviation is 11.32.
  • The fund has a Value at Risk (VaR) of -15.67 and a maximum drawdown of -12.33. The category average VaR is -19.09 and the maximum drawdown is -14.79. The fund has a beta of 0.77 which shows that fund is less volatile than the benchmark.

Standard deviation measures the fund's return volatility and Semi deviation focuses on downside volatility. Value at Risk (VaR) is a measure of the risk of investments. Maximum Drawdown is the maximum loss from a peak to a trough of a portfolio. Beta measures the volatility of the fund compared to the benchmark. A beta of 1 indicates that the fund will move in line with the benchmark. A beta of more than 1 indicates that the fund will be more volatile than the benchmark and vice versa.


  • Very Good Performance in Pharma Fund Category
  • Good Performance in Pharma Fund Category
  • Poor Performance in Pharma Fund Category
  • Very Poor Performance in Pharma Fund Category

  • Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

    Data Source: www.amfiindia.com

    SEBI Categorization


    KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % 3.65 2.37
    3.04
    1.32 | 5.61 7 | 16 Good
    3M Return % 10.71 4.86
    9.50
    5.14 | 12.91 7 | 16 Good
    6M Return % 11.08 7.24
    8.33
    3.22 | 13.97 3 | 16 Very Good
    1Y Return % 10.66 11.55
    9.75
    4.62 | 18.10 6 | 15 Good
    3Y Return % 25.21 24.71
    24.26
    22.21 | 26.76 3 | 8 Good
    5Y Return % 15.51 11.87
    13.75
    12.39 | 15.51 1 | 8 Very Good
    7Y Return % 23.12 17.80
    22.17
    20.24 | 23.23 2 | 7 Very Good
    10Y Return % 13.36 9.34
    13.90
    13.18 | 15.27 3 | 4 Average
    15Y Return % 16.80 12.22
    15.78
    14.49 | 16.80 1 | 3 Very Good
    1Y SIP Return % 18.54
    15.74
    7.07 | 24.98 5 | 15 Good
    3Y SIP Return % 17.17
    14.82
    11.81 | 17.29 2 | 8 Very Good
    5Y SIP Return % 19.63
    17.23
    15.29 | 19.63 1 | 8 Very Good
    7Y SIP Return % 20.95
    19.30
    17.38 | 20.95 1 | 7 Very Good
    10Y SIP Return % 18.16
    17.31
    16.41 | 18.16 1 | 4 Very Good
    15Y SIP Return % 16.51
    16.05
    15.24 | 16.51 1 | 3 Very Good
    Standard Deviation 14.75
    15.97
    14.75 | 16.83 1 | 8 Very Good
    Semi Deviation 10.70
    11.32
    10.52 | 12.07 2 | 8 Very Good
    Max Drawdown % -12.33
    -14.79
    -16.36 | -12.33 1 | 8 Very Good
    VaR 1 Y % -15.67
    -19.09
    -23.30 | -15.67 1 | 8 Very Good
    Average Drawdown % -5.39
    -5.48
    -6.79 | -3.72 4 | 8 Good
    Sharpe Ratio 1.20
    1.01
    0.85 | 1.20 1 | 8 Very Good
    Sterling Ratio 1.09
    0.92
    0.79 | 1.09 1 | 8 Very Good
    Sortino Ratio 0.63
    0.53
    0.43 | 0.63 1 | 8 Very Good
    Jensen Alpha % 4.20
    0.91
    -2.04 | 4.20 1 | 8 Very Good
    Treynor Ratio -0.46
    -0.43
    -0.48 | -0.40 7 | 8 Poor
    Modigliani Square Measure % 27.07
    23.67
    20.89 | 27.07 1 | 8 Very Good
    Alpha % -1.04
    -1.43
    -3.34 | 1.08 3 | 8 Good
    Return data last Updated On : June 12, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : March 30, 2026
    KPIs: Key Performance Indicators

    Rotate the phone! Best viewed in landscape mode on mobile.
    KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % 3.74 2.37 3.16 1.37 | 5.73 7 | 16 Good
    3M Return % 10.98 4.86 9.88 5.37 | 13.28 8 | 16 Good
    6M Return % 11.64 7.24 9.06 3.95 | 14.89 3 | 16 Very Good
    1Y Return % 11.79 11.55 11.23 5.59 | 19.48 7 | 15 Good
    3Y Return % 26.52 24.71 25.72 23.31 | 27.82 4 | 8 Good
    5Y Return % 16.74 11.87 15.12 13.40 | 16.74 1 | 8 Very Good
    7Y Return % 24.44 17.80 23.64 22.04 | 24.78 3 | 7 Good
    10Y Return % 14.61 9.34 15.20 14.61 | 16.30 4 | 4 Poor
    1Y SIP Return % 19.71 17.26 8.59 | 26.46 5 | 15 Good
    3Y SIP Return % 18.40 16.19 13.27 | 18.47 2 | 8 Very Good
    5Y SIP Return % 20.89 18.62 16.51 | 20.89 1 | 8 Very Good
    7Y SIP Return % 22.26 20.75 19.00 | 22.26 1 | 7 Very Good
    10Y SIP Return % 19.38 18.61 18.17 | 19.38 1 | 4 Very Good
    Standard Deviation 14.75 15.97 14.75 | 16.83 1 | 8 Very Good
    Semi Deviation 10.70 11.32 10.52 | 12.07 2 | 8 Very Good
    Max Drawdown % -12.33 -14.79 -16.36 | -12.33 1 | 8 Very Good
    VaR 1 Y % -15.67 -19.09 -23.30 | -15.67 1 | 8 Very Good
    Average Drawdown % -5.39 -5.48 -6.79 | -3.72 4 | 8 Good
    Sharpe Ratio 1.20 1.01 0.85 | 1.20 1 | 8 Very Good
    Sterling Ratio 1.09 0.92 0.79 | 1.09 1 | 8 Very Good
    Sortino Ratio 0.63 0.53 0.43 | 0.63 1 | 8 Very Good
    Jensen Alpha % 4.20 0.91 -2.04 | 4.20 1 | 8 Very Good
    Treynor Ratio -0.46 -0.43 -0.48 | -0.40 7 | 8 Poor
    Modigliani Square Measure % 27.07 23.67 20.89 | 27.07 1 | 8 Very Good
    Alpha % -1.04 -1.43 -3.34 | 1.08 3 | 8 Good
    Return data last Updated On : June 12, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : March 30, 2026
    KPIs: Key Performance Indicators

    Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


    Date Sbi Healthcare Opportunities Fund NAV Regular Growth Sbi Healthcare Opportunities Fund NAV Direct Growth
    12-06-2026 472.167 545.6258
    11-06-2026 469.761 542.831
    10-06-2026 468.0804 540.8745
    09-06-2026 469.7059 542.7383
    08-06-2026 465.411 537.7611
    05-06-2026 465.5393 537.8663
    04-06-2026 461.2136 532.8558
    03-06-2026 459.0647 530.3589
    02-06-2026 455.8959 526.6839
    01-06-2026 456.4327 527.2899
    29-05-2026 459.3345 530.5996
    27-05-2026 463.1159 534.9391
    26-05-2026 465.3349 537.4877
    25-05-2026 465.8098 538.0219
    22-05-2026 466.2556 538.4936
    21-05-2026 470.6362 543.5384
    20-05-2026 467.2993 539.6701
    19-05-2026 466.7555 539.0277
    18-05-2026 464.007 535.8392
    15-05-2026 461.2721 532.6382
    14-05-2026 462.516 534.0602
    13-05-2026 457.2003 527.9082
    12-05-2026 455.5256 525.9604

    Fund Launch Date: 01/Jan/1993
    Fund Category: Pharma Fund
    Investment Objective: To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
    Fund Description: An open-ended Equity Scheme investing in healthcare sector
    Fund Benchmark: S&P BSE HEALTHCARE Index
    Source: Fund FactSheet

    Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.